Published in Histol Histopathol on January 01, 1997
The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci (2010) 2.61
Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol (2002) 2.12
Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol (2004) 1.83
Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Pathol (2002) 1.59
Extrafoveal traction in retinal vein occlusion using spectral domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2011) 1.51
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J Clin Invest (2008) 1.39
Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol (1999) 1.31
The effectiveness of vitrectomy for diffuse diabetic macular edema may depend on its preoperative optical coherence tomography pattern. Graefes Arch Clin Exp Ophthalmol (2016) 1.30
Critical appraisal of ranibizumab in the treatment of diabetic macular edema. Clin Ophthalmol (2013) 1.23
Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol (1998) 1.20
[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]. Ophthalmologe (2006) 1.19
Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of Mycobacterium tuberculosis. PLoS One (2011) 1.09
Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am J Pathol (2000) 1.07
Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol (1997) 1.04
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability. J Ophthalmol (2011) 1.02
Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol (2009) 1.00
Macular oedema: the role of soluble mediators. Br J Ophthalmol (2000) 0.98
Alternative therapies in exudative age related macular degeneration. Br J Ophthalmol (1998) 0.93
Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion. Indian J Ophthalmol (2014) 0.92
MicroRNA-200b downregulates oxidation resistance 1 (Oxr1) expression in the retina of type 1 diabetes model. Invest Ophthalmol Vis Sci (2013) 0.92
Ocular Effects of Niacin: A Review of the Literature. Med Hypothesis Discov Innov Ophthalmol (2015) 0.88
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration. Clin Ophthalmol (2015) 0.87
Emerging pharmacotherapies for diabetic macular edema. Exp Diabetes Res (2012) 0.86
Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. Int Ophthalmol (2007) 0.85
Pharmacotherapies for diabetic retinopathy: present and future. Exp Diabetes Res (2007) 0.82
Basic fibroblast growth factor contributes to a shift in the angioregulatory activity of retinal glial (Müller) cells. PLoS One (2013) 0.81
Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders. J Ophthalmic Vis Res (2009) 0.80
Blockade of VEGF-induced GSK/β-catenin signaling, uPAR expression and increased permeability by dominant negative p38α. Exp Eye Res (2012) 0.80
Early Avastin management in acute retinal vein occlusion. Saudi J Ophthalmol (2010) 0.79
Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling. Invest Ophthalmol Vis Sci (2014) 0.79
Delayed corneal epithelial healing after intravitreal bevacizumab: a clinical and experimental study. J Ophthalmic Vis Res (2011) 0.78
Nuclear factor kappa-B signaling is integral to ocular neovascularization in ischemia-independent microenvironment. PLoS One (2014) 0.78
Diabetic macular edema: therapeutic options. Diabetes Ther (2012) 0.78
Relationship between Oxidative Stress, Circadian Rhythms, and AMD. Oxid Med Cell Longev (2015) 0.78
The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases. Mediators Inflamm (2014) 0.77
VEGF Receptor-2-Linked PI3K/Calpain/SIRT1 Activation Mediates Retinal Arteriolar Dilations to VEGF and Shear Stress. Invest Ophthalmol Vis Sci (2015) 0.77
NADPH oxidase 4-derived H2O2 promotes aberrant retinal neovascularization via activation of VEGF receptor 2 pathway in oxygen-induced retinopathy. J Diabetes Res (2015) 0.77
Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization. Ther Clin Risk Manag (2013) 0.76
Steroids in Central Retinal Vein Occlusion: Is There a Role in Current Treatment Practice? J Ophthalmol (2015) 0.75
Suppressed endothelin-1 by anti-VEGF therapy is important for patients with BRVO-related macular edema to improve their vision. EPMA J (2016) 0.75
VEGF165-induced vascular permeability requires NRP1 for ABL-mediated SRC family kinase activation. J Exp Med (2017) 0.75
Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions. Arch Med Sci (2016) 0.75
Cystoid puncture for chronic cystoid macular oedema. Br J Ophthalmol (2007) 0.75
Treatment of serous retinal detachment associated with choroidal ischemia with intravitreal bevacizumab following brain surgery. Korean J Ophthalmol (2014) 0.75
Implication of VEGF and aquaporin 4 mediating Müller cell swelling to diabetic retinal edema. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med (2001) 24.51
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 7.84
Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis (1998) 7.51
Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol (1989) 6.53
Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol (1982) 6.39
Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol (1981) 5.09
mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet (1994) 4.47
Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology (1985) 3.83
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci U S A (1999) 3.66
Ocular explosion after peribulbar anesthesia: case report and experimental study. Ophthalmology (1997) 3.59
Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol (1983) 3.42
Ocular explosions from periocular anesthetic injections: a clinical, histopathologic, experimental, and biophysical study. Ophthalmology (1999) 3.35
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90
Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol (1997) 2.73
Pathologic features of senile macular degeneration. Ophthalmology (1985) 2.73
Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA (1986) 2.69
mtDNA and Y-chromosome polymorphisms in four Native American populations from southern Mexico. Am J Hum Genet (1994) 2.68
A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol (1988) 2.68
Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol (1982) 2.61
Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology (1988) 2.59
Comparison of invasive and noninvasive tests for detecting Helicobacter pylori infection in bleeding peptic ulcers. Gastrointest Endosc (1999) 2.51
Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus) N Engl J Med (1995) 2.47
Conjunctival lesions in adults. A clinical and histopathologic review. Cornea (1987) 2.43
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol (2000) 2.41
Unilateral Duane's retraction syndrome (Type 1). Arch Ophthalmol (1982) 2.40
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol (1981) 2.34
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol (1983) 2.30
A histopathologic study of Best's macular dystrophy. Arch Ophthalmol (1982) 2.27
Ocular and orbital involvement in leukemia. Surv Ophthalmol (1983) 2.26
Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci (1999) 2.23
Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc (1977) 2.20
Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol (1983) 2.19
Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol (1999) 2.18
Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology (1994) 2.16
Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron (1999) 2.15
Pathologic findings in pathologic myopia. Retina (1992) 2.14
Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol (1990) 2.13
Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology (1984) 2.12
Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology (1993) 2.10
Lesions of the caruncle: a clinicohistopathologic study. Surv Ophthalmol (1979) 2.08
Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina (1981) 2.05
Bilateral Duane's retraction syndrome. A clinical-pathologic case report. Arch Ophthalmol (1980) 2.01
Subretinal fluid stimulation of retinal pigment epithelial cell migration and proliferation is dependent on certain features of the detachment or its treatment. Arch Ophthalmol (1989) 1.98
The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology (1979) 1.97
Histologic studies of the vasculature of the anterior optic nerve. Am J Ophthalmol (1976) 1.96
Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol (2001) 1.94
X-linked ocular albinism. An oculocutaneous macromelanosomal disorder. Arch Ophthalmol (1976) 1.94
Primary adenocarcinoma of the lacrimal gland. A retrospective study. Ophthalmology (1993) 1.93
A histopathologic review of 168 cases of preretinal membrane. Am J Ophthalmol (1977) 1.93
Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade. Retina (1992) 1.91
Temperature- and light-dependent structural changes in rhodopsin-lipid membranes. Exp Eye Res (1973) 1.89
Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch Ophthalmol (1994) 1.88
White centered hemorrhages: their significance. Ophthalmology (1980) 1.88
Epibulbar tumors in childhood. Am J Ophthalmol (1975) 1.88
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther (2006) 1.86
Sebaceous gland carcinoma. Review of 40 cases. Arch Ophthalmol (1984) 1.83
Neurotoxic effects of cisplatin therapy. Arch Neurol (1982) 1.83
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema. Br J Ophthalmol (2009) 1.82
Mitochondrial DNA sequence diversity in bipolar affective disorder. Am J Psychiatry (2000) 1.77
Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology (1989) 1.76
Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 cases. Am J Med (2001) 1.76
Leber hereditary optic neuropathy. Electron microscopy and molecular genetic analysis of a case. Ophthalmology (1995) 1.74
Senile disciform degeneration of the macula. Retinal arterialization of the fibrous plaque demonstrated clinically and histopathologically. Arch Ophthalmol (1971) 1.74
Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina (1994) 1.72
Transforming growth factor beta. A biologic chorioretinal glue. Arch Ophthalmol (1989) 1.71
Retinal pathologic changes in multiple sclerosis. Retina (1994) 1.71
Clinical biochemical and pathologic correlations in Bietti's crystalline dystrophy. Am J Ophthalmol (1994) 1.70
Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med (1999) 1.70
Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci (1998) 1.68
Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci (2000) 1.68
IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol (1997) 1.68
Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion. Retina (2001) 1.67
Posterior capsule opacification in pseudophakic eyes. Ophthalmology (1983) 1.66
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65
Structural abnormalities develop in the brain after ablation of the gene encoding nonmuscle myosin II-B heavy chain. J Comp Neurol (2001) 1.63
Toxicity of intravitreous ceftazidime in primate retina. Arch Ophthalmol (1992) 1.63
Histopathology of commotio retinae. Retina (1992) 1.62
CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause. J Immunol (1997) 1.62
Respiratory symptoms of primary school children living in a petrochemical polluted area in Taiwan. Pediatr Pulmonol (1998) 1.61
Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res (1997) 1.58
Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis. Am J Ophthalmol (1989) 1.57
Asperillosis of the orbit. Report of ten cases and review of the literature. Arch Ophthalmol (1969) 1.56
The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol (2001) 1.56
Clinicopathologic correlation of surgically removed macular hole opercula. Am J Ophthalmol (1995) 1.55
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530. Bioorg Med Chem Lett (1998) 1.54
Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum Pathol (1987) 1.54
The effect of a bi-annual professional application of APF foam on dental caries increment in primary teeth: 24-month clinical trial. J Dent Res (2005) 1.53
Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol (1994) 1.53
Case report: portal vein thrombosis associated with hereditary protein C deficiency: a report of two cases. J Gastroenterol Hepatol (1999) 1.52
Single and multiple pyogenic liver abscesses: clinical course, etiology, and results of treatment. World J Surg (1997) 1.52
Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc (1981) 1.52